A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer-Experiences of the mother

International Journal of Epidemiology

Volumn 38, Issue 6, 2009, Pages 1532-1542

  Cook, Michael B ^a   Akre, Olof ^b   Forman, David ^c   Madigan, M Patricia ^a   Richiardi, Lorenzo ^d   McGlynn, Katherine A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Epidemiology; Meta analysis; Pregnancy; Review; Systematic; Testicular neoplasms

Indexed keywords

CANCER; DATABASE; EPIDEMIOLOGY; HEALTH RISK; LITERATURE REVIEW; META-ANALYSIS; PREGNANCY; REGRESSION ANALYSIS; RISK FACTOR;

BIRTH ORDER; BLEEDING; BREECH EXTRACTION; CANCER RISK; CESAREAN SECTION; EMBASE; EXPERIENCE; HUMAN; MATERNAL AGE; MATERNAL HYPERTENSION; MEDLINE; MOTHER; NAUSEA; PERINATAL PERIOD; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TESTIS CANCER; FEMALE; MALE; META ANALYSIS; PERINATAL CARE; PREGNANCY COMPLICATION; RISK FACTOR; SIBLING; TESTIS TUMOR; UTERUS BLEEDING;

SCOPUS;

BIRTH ORDER; CESAREAN SECTION; FEMALE; HUMANS; MALE; MATERNAL AGE; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SIBLINGS; TESTICULAR NEOPLASMS; UTERINE HEMORRHAGE;

EID: 75349092158     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp287     Document Type: Review

References (64)

1. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003;97: 63-70.
2. IARC. Cancer incidence in five continents. Vol. IX. IARC Sci Publ, No 160, 2008;1-897.
3. Muller J, Skakkebaek NE, Nielsen OH, Graem N. Cryptorchidism and testis cancer. Atypical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthood. Cancer 1984;54:629-34.
4. Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987;10: 19-28.
5. Moller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993; 23:8-13; discussion 4-5.
6. Looijenga LH, de Leeuw H, van Oorschot M et al. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 2003;63:7674-78.
7. Looijenga LH, Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis. Ann N Y Acad Sci 2007;1120: 187-214.
8. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 2006;12: 303-23.
9. Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 2006;118: 3099-111.
10. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003;170: 5-11.
11. Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer 2005;115:822-27.
12. McGlynn KA. Environmental and host factors in testicular germ cell tumors. Cancer Invest 2001;19:842-53.
13. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004;22:2-14.
14. Thomson Reuters. EndNote X2.0.1. Thomson Reuters, 2008.
15. Chene G, Thompson SG. Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 1996;144: 610-21.
16. Sata Corp. Stata Statistical Software: Release 10. College Station, Texas: StataCorp LP, 2007.
17. Woolf B. On estimating the relationship between blood group and disease. Ann Hum Genet 1955;19:251-53.
18. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
21. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21:1559-73.
22. Sharp SJ. Meta-analysis regression. Stata Technical Bulletin 1998;16-22.
23. Aschim EL, Haugen TB, Tretli S, Daltveit AK, Grotmol T. Risk factors for testicular cancer-differences between pure non-seminoma and mixed seminoma/non-seminoma? Int J Androl 2006;29:458-67.
24. Pettersson A, Richiardi L, Cnattingius S, Kaijser M, Akre O. Gestational hypertension, preeclampsia, and risk of testicular cancer. Cancer Res 2008;68:8832-36.
25. Alexander JD, Schneider FD. Vaginal bleeding associated with pregnancy. Prim Care 2000;27:137-51.
26. Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE. Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 1986;76:1035-39.
27. Panagiotopoulou K, Katsouyanni K, Petridou E, Garas Y, Tzonou A, Trichopoulos D. Maternal age, parity, and pregnancy estrogens. Cancer Causes Control 1990;1: 119-24.
28. Troisi R, Hoover RN, Thadhani R et al. Maternal, prenatal and peri-natal characteristics and first trimester maternal serum hormone concentrations. Br J Cancer 2008;99: 1161-64.
29. Arslan AA, Zeleniuch-Jacquotte A, Lukanova A et al. Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer. Cancer Epidemiol Biomark Prevention 2006;15:2123-30.
30. Ford AC, Forman D, Bailey AG, Goodman KJ, Axon AT, Moayyedi P. Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study. Int J Epidemiol 2007;36:1327-33.
31. Green MS, Zaaide Y. Sibship size as a risk factor for hepatitis A infection. Am J Epidemiol 1989;129:800-5.
32. Richiardi L, Akre O, Lambe M, Granath F, Montgomery SM, Ekbom A. Birth order, sibship size, and risk for germ-cell testicular cancer. Epidemiology 2004;15:323-29.
33. Altieri A, Hemminki K. Number of siblings and the risk of solid tumours: a nation-wide study. Br J Cancer 2007; 96:1755-59.
34. Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta-1968-2000: teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol 2004;70:572-79.
35. Merrill RM, Fugal S, Novilla LB, Raphael MC. Cancer risk associated with early and late maternal age at first birth. Gynecol Oncol 2005;96:583-93.
36. Goodwin TM. Hyperemesis gravidarum. Obstet Gynecol Clin North Am 2008;35:401-17, viii.
37. Cook MB, Graubard BI, Rubertone MV, Erickson RL, McGlynn KA. Perinatal factors and the risk of testicular germ cell tumors. Int J Cancer 2008;122:2600-6.
38. Coupland CA, Forman D, Chilvers CE, Davey G, Pike MC, Oliver RT. Maternal risk factors for testicular cancer: a population-based case-control study (UK). Cancer Causes Control 2004;15:277-83.
39. Dieckmann KP, Endsin G, Pichlmeier U. How valid is the prenatal estrogen excess hypothesis of testicular germ cell cancer? A case control study on hormone-related factors. Eur Urol 2001;40:677-83.
40. Dusek L, Abrahamova J, Lakomy R et al. Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic. Neoplasma 2008;55:356-68.
41. English PB, Goldberg DE, Wolff C, Smith D. Parental and birth characteristics in relation to testicular cancer risk among males born between 1960 and 1995 in California (United States). Cancer Causes Control 2003;14:815-25.
42. Janerich DT, Hayden CL, Thompson WD, Selenskas SL, Mettlin C. Epidemiologic evidence of peri-natal influence in the etiology of adult cancers. J Clin Epidemiol 1989;42: 151-57.
43. Moller H, Skakkebaek NE. Risks of testicular cancer and cryptorchidism in relation to socio-economic status and related factors: case-control studies in Denmark. Int J Cancer 1996;66:287-93.
44. Petridou E, Roukas KI, Dessypris N et al. Baldness and other correlates of sex hormones in relation to testicular cancer. Int J Cancer 1997;71:982-85.
45. Sabroe S, Olsen J. Perinatal correlates of specific histological types of testicular cancer in patients below 35 years of age: a case-cohort study based on midwives' records in Denmark. Int J Cancer 1998;78:140-3.
46. Sonke GS, Chang S, Strom SS, Sweeney AM, Annegers JF, Sigurdson AJ. Prenatal and peri-natal risk factors and testicular cancer: a hospital-based case-control study. Oncol Res 2007;16:383-87.
47. Swerdlow AJ, Huttly SR, Smith PG. Prenatal and familial associations of testicular cancer. Br J Cancer 1987;55: 571-77.
48. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 2000;87:438-43.
49. Akre O, Ekbom A, Hsieh CC, Trichopoulos D, Adami HO. Testicular nonseminoma and seminoma in relation to peri-natal characteristics. J Natl Cancer Inst 1996;88: 883-89.
50. Richiardi L, Akre O, Bellocco R, Ekbom A. Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br J Cancer 2002;87:545-50.
51. Moller H, Skakkebaek NE. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control 1997;8:904-12.
52. Wanderas EH, Grotmol T, Fossa SD, Tretli S. Maternal health and pre-and peri-natal characteristics in the etiology of testicular cancer: a prospective population-and register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 1998;9:475-86.
53. Mogren IDLTBHU. Characteristics of pregnancy and birth and malignancy in the offspring (Sweden). Cancer Causes Control 1999;10:85-94.
54. Brown LM, Pottern LM, Hoover RN. Prenatal and peri-natal risk factors for testicular cancer. Cancer Res 1986;46: 4812-86.
55. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 1983;71:1151-55.
56. Mori M, Davies TW, Miyake H, Masuoka H, Kumamoto Y, Tsukamoto T. Maternal factors of testicular cancer: a case-control study in Japan. Jpn J Clin Oncol 1990;20:72-77.
57. Moss AR, Osmond D, Bacchetti P, Torti FM, Gurgin V. Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol 1986;124:39-52.
58. Henderson BE, Benton B, Jing J, Yu MC, Pike MC. Risk factors for cancer of the testis in young men. Int J Cancer 1979;23:598-602.
59. Gershman ST, Stolley PD. A case-control study of testicular cancer using Connecticut tumour registry data. Int J Epidemiol 1988;17:738-42.
60. Schottenfeld D, Warshauer ME, Sherlock S, Zauber AG, Leder M, Payne R. The epidemiology of testicular cancer in young adults. Am J Epidemiol 1980; 112:232-46.
61. Heimdal K, Andersen TI, Skrede M, Fossa SD, Berg K, Borresen AL. Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population. Cancer Epidemiol Biomarkers Prev 1995; 4:123-26.
62. Prener A, Hsieh CC, Engholm G, Trichopoulos D, Jensen OM. Birth order and risk of testicular cancer. Cancer Causes Control 1992;3:265-72.
63. Westergaard T, Andersen PK, Pedersen JB, Frisch M, Olsen JH, Melbye M. Testicular cancer risk and maternal parity: a population-based cohort study. Br J Cancer 1998; 77:1180-85.
64. Morrison AS. Some social and medical characteristics of Army men with testicular cancer. Am J Epidemiol 1976; 104:511-16.